Seunghyun Kim

发表

Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study

J. Lee, Ji Young Kim, Y. Choi, 2017, Journal of Translational Medicine.

Phase I Trial of Repeated Intrathecal Autologous Bone Marrow‐Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis

Hyun Young Kim, K. Kim, Jinseok Park, 2015, Stem cells translational medicine.

Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF‐β Secretion

Kyung-Ah Cho, K. Kim, Jinseok Park, 2016, Stem cells translational medicine.

Plasma miRNA-214 is a predictive candidate biomarker of progression speed in patients with ALS

Minyeop Nahm, Young-Eun Kim, H. Jin, 2022, bioRxiv.

ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics

Yong Ho Kim, Jinhyuk Lee, Minyeop Nahm, 2019, Science Translational Medicine.

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial

J. Sung, B. Kim, K. Kim, 2022, Trials.

Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease

Xiang-Dong Fu, C. Ki, Minyeop Nahm, 2016, Oncotarget.

Biological Markers of Mesenchymal Stromal Cells as Predictors of Response to Autologous Stem Cell Transplantation in Patients With Amyotrophic Lateral Sclerosis: An Investigator‐Initiated Trial and In Vivo Study

S. Koh, Heejaung Kim, S. H. Kim, 2014, Stem cells.

Acid sphingomyelinase inhibition improves motor behavioral deficits and neuronal loss in an amyotrophic lateral sclerosis mouse model

Kang Ho Park, E. Huang, H. Jin, 2022, BMB reports.

Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models.

Minyeop Nahm, S. Cha, Hyun-Jun Choi, 2022, Developmental cell.

Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis

Seungbok Lee, Jinhyuk Lee, Xiang-Dong Fu, 2016, Molecular Neurodegeneration.

25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis

J. Sung, K. Park, Hee-Soo Kim, 2017, Oncotarget.

Discovery of a dual-action small molecule that improves neuropathological features of Alzheimer’s disease mice

Kang Ho Park, E. Schuchman, H. Jin, 2022, Proceedings of the National Academy of Sciences.

Neural Induction with Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model

S. H. Kim, Hee-Jin Kim, Young-don Lee, 2013, Cell transplantation.

Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma

H. Woo, S. Choi, Soon-Tae Lee, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Genetic Screening in Korean Patients with Frontotemporal Dementia Syndrome

Young Ho Park, D. Na, S. Seo, 2022, Journal of Alzheimer's disease reports.

Distal hereditary motor neuropathy type 7B with Dynactin 1 mutation.

Byung-Ok Choi, Y. Hong, K. Chung, 2016, Molecular medicine reports.

Diversity of ion channels in human bone marrow mesenchymal stem cells from amyotrophic lateral sclerosis patients.

M. Choi, K. Jung, Kyoung Sun Park, 2008, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathy

Ji Eun Lee, H. Kim, Won Min Mo, 2016, Annals of neurology.

Usefulness of diffusion tensor imaging findings as biomarkers for amyotrophic lateral sclerosis

W. Tae, Y. Kim, Byung-Jo Kim, 2020, Scientific Reports.

Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study

J. Lee, Ji Young Kim, Y. Choi, 2017, Journal of Translational Medicine.

Intermittent Hypoxia Can Aggravate Motor Neuronal Loss and Cognitive Dysfunction in ALS Mice

Kwang-Woo Lee, J. Sung, Suk-Won Ahn, 2013, PloS one.

Long-term survival benefits of intrathecal autologous bone marrow-derived mesenchymal stem cells (Neuronata-R®: lenzumestrocel) treatment in ALS: Propensity-score-matched control, surveillance study

Jae-Yong Nam, Ju-Yong Oh, Sanggon Lee, 2023, Frontiers in Aging Neuroscience.

Efficacy and safety of Lenzumestrocel (Neuronata-R® inj.) in patients with amyotrophic lateral sclerosis (ALSUMMIT study): study protocol for a multicentre, randomized, double-blind, parallel-group, sham procedure-controlled, phase III trial

J. Sung, B. Kim, Byung-Jo Kim, 2022, Trials.

Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia

D. Na, C. Ki, J. Jeong, 2014, Neurobiology of Aging.

Prognosis of Patients with Behavioral Variant Frontotemporal Dementia Who have Focal Versus Diffuse Frontal Atrophy

D. Knopman, D. Na, S. Seo, 2016, Journal of clinical neurology.

Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants

Yong Ho Kim, Minyeop Nahm, Young-Eun Kim, 2022, Brain Communications.

Evolving Diagnostic Criteria in Amyotrophic Lateral Sclerosis and Its Differential Diagnosis

Ki-Wook Oh, Seunghyun Kim, 2023, Korean Journal of Neuromuscular Disorders.